Insulin Glargine (U-100) Cartridge Systems and Pens and Sarilumab Subcutaneous
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Sarilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Sarna Hc Topical application
- Insulin Glargine (U-100) Cartridge Systems and Pens-Sarnol-HC
- Insulin Glargine (U-100) Cartridge Systems and Pens-Sarnol-HC Maximum Strength
- Insulin Glargine (U-100) Cartridge Systems and Pens-SAStid
- Insulin Glargine (U-100) Cartridge Systems and Pens-Sastid Soap Topical
- Insulin Glargine (U-100) Cartridge Systems and Pens-SAStid Topical
- Sarilumab Subcutaneous-Insulin Glargine (U-100) Vials
- Sarilumab Subcutaneous-Insulin Glargine (U-300) Pens
- Sarilumab Subcutaneous-Insulin glargine and lixisenatide
- Sarilumab Subcutaneous-Insulin glargine and lixisenatide Subcutaneous
- Sarilumab Subcutaneous-Insulin glargine, recombinant Subcutaneous
- Sarilumab Subcutaneous-Insulin glulisine